TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15778862

Group type: EXPERIMENTAL
Intervention: Azithromycin (single dose)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Doxycycline (twice-daily for 7 days)
Number of subjects: 81
Study: 11835022

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Warfarin in addition to aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral GP IIb/IIIa inhibitors
Number of subjects: 0
Study: 12579695

Group type: EXPERIMENTAL
Intervention: Fresh amniotic membrane transplantation (AMT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Preserved amniotic membrane transplantation (AMT)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Fresh AMT
Number of subjects: 39

Group type: COMPARATOR
Intervention: Preserved AMT
Number of subjects: 39
Study: 8665975

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hydralazine
Number of subjects: 30
Study: 2087820

Group type: EXPERIMENTAL
Intervention: 300 mg ranitidine given after an early evening meal (6 p.m.)
Number of subjects: 279

Group type: COMPARATOR
Intervention: 300 mg ranitidine given at bedtime (10 p.m.)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: 300 mg ranitidine (early evening) for patients with ulcer diameter 5 mm to 9.5 mm and a history of duodenal ulcer
Number of subjects: 279
Study: 467056

Group type: EXPERIMENTAL
Intervention: Paper formulation of oral contraceptive
Number of subjects: 270

Group type: COMPARATOR
Intervention: Conventional tablet of oral contraceptive
Number of subjects: 270
Study: 30303436

Group type: EXPERIMENTAL
Intervention: PCV13+QIV
Number of subjects: 882

Group type: COMPARATOR
Intervention: Placebo+QIV
Number of subjects: 882

Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 882
Study: 27348601

Group type: EXPERIMENTAL
Intervention: CRVO patients
Number of subjects: 72

Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: CRVO patients under 75 years
Number of subjects: 72

Group type: COMPARATOR
Intervention: Matched controls under 75 years
Number of subjects: 72
Study: 25796058

Group type: EXPERIMENTAL
Intervention: SPLA-TUM
Number of subjects: 92

Group type: COMPARATOR
Intervention: SP-LM
Number of subjects: 92
Study: 23541061

Group type: EXPERIMENTAL
Intervention: CGS impregnated with bFGF at 7 or 14 μg/cm(2) after debridement
Number of subjects: 17

Group type: COMPARATOR
Intervention: CGS impregnated with bFGF (low-dose group)
Number of subjects: 17

Group type: COMPARATOR
Intervention: CGS impregnated with bFGF (high-dose group)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: CGS impregnated with bFGF
Number of subjects: 17
Study: 20647949

Group type: COMPARATOR
Intervention: PNF40
Number of subjects: 15

Group type: COMPARATOR
Intervention: PNF60
Number of subjects: 15

Group type: COMPARATOR
Intervention: PNF80
Number of subjects: 15
Study: 22128425

Group type: EXPERIMENTAL
Intervention: Acupuncture after administration of aspirin 500 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Acupuncture after administration of placebo
Number of subjects: 14
Study: 17126656

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 15051597

Group type: EXPERIMENTAL
Intervention: 0.7 g DHA/d for 3 months
Number of subjects: 38
Study: 11720771

Group type: EXPERIMENTAL
Intervention: Induced gamma band responses (GBRs) during the recall sequence of the learning condition.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phase synchrony between electrode sites during the recall sequence of the learning condition.
Number of subjects: 0
Study: 8998089

Group type: EXPERIMENTAL
Intervention: CPOU (chest pain observation unit)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard inpatient hospitalization
Number of subjects: 104
Study: 8328365

Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg once daily
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study: 3521843

Group type: EXPERIMENTAL
Intervention: Secobarbital sodium plus chlorpromazine (SC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Metoclopramide, diphenhydramine, and dexamethasone (MDD)
Number of subjects: 18
Study: 29047142

Group type: EXPERIMENTAL
Intervention: FOLFIRI plus cetuximab (anti-EGFR)
Number of subjects: 400

Group type: COMPARATOR
Intervention: FOLFIRI plus bevacizumab (anti-VEGF)
Number of subjects: 400
Study: 26933803

Group type: EXPERIMENTAL
Intervention: D-serine administration
Number of subjects: 50
Study: 24914089

Group type: EXPERIMENTAL
Intervention: Intensified care group (ICG)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard care group (SCG)
Number of subjects: 74
Study: 22801200

Group type: EXPERIMENTAL
Intervention: Pulmonary surfactant by tracheal instillation during mechanical ventilation postoperatively
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no pulmonary surfactant treatment)
Number of subjects: 23
Study: 20536474

Group type: EXPERIMENTAL
Intervention: Barrier cream application alone
Number of subjects: 1020

Group type: COMPARATOR
Intervention: Skin care
Number of subjects: 1020

Group type: COMPARATOR
Intervention: Skin protection
Number of subjects: 1020

Group type: COMPARATOR
Intervention: Both combined
Number of subjects: 1020

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1020
Study: 18272338

Group type: EXPERIMENTAL
Intervention: Penrose rubber drain inserted into the extraction socket after surgery and left for 72 h
Number of subjects: 100

Group type: COMPARATOR
Intervention: No rubber drain used (Control)
Number of subjects: 100
Study: 15902851

Group type: EXPERIMENTAL
Intervention: Minimally invasive approach (8 cm incision)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard approach (15 cm incision)
Number of subjects: 60
Study: 14577892

Group type: EXPERIMENTAL
Intervention: Writing about recalled negative experiences (RNE group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Drawing about recalled negative experiences (RNE group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Drawing-and-writing about recalled negative experiences (RNE group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Writing on neutral topics (NT group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Drawing on neutral topics (NT group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Drawing-and-writing on neutral topics (NT group)
Number of subjects: 100
Study: 11083136

Group type: EXPERIMENTAL
Intervention: Early OC use (days 7-9)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Late OC use (days 19-21)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Off OC use (days 2-4)
Number of subjects: 10
Study: 9538713

Group type: EXPERIMENTAL
Intervention: Tympanic membrane temperature using the Diatek 9000 InstaTemp thermometer
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Axilla temperature using the Tempa.DOT Ax chemical thermometer
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pulmonary artery blood temperature (gold standard)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fan therapy directed to the head
Number of subjects: 60
Study: 8517426

Group type: EXPERIMENTAL
Intervention: Bisoprolol (10 to 20 mg)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Atenolol (50 to 100 mg)
Number of subjects: 203
Study: 3525990

Group type: EXPERIMENTAL
Intervention: Beaded catheters
Number of subjects: 41

Group type: COMPARATOR
Intervention: Unbeaded catheters
Number of subjects: 41
Study: 30212861

Group type: EXPERIMENTAL
Intervention: Early adenotonsillectomy (eAT)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Watchful waiting with supportive care (WWSC)
Number of subjects: 176
Study: 27046619

Group type: EXPERIMENTAL
Intervention: Stereoscopic simulation (stereo group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-stereoscopic simulation (non-stereo group)
Number of subjects: 20
Study: 26525387

Group type: EXPERIMENTAL
Intervention: High-status e-confederates
Number of subjects: 304

Group type: COMPARATOR
Intervention: Low-status e-confederates
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Public session
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Private session
Number of subjects: 304
Study: 22935549

Group type: EXPERIMENTAL
Intervention: Completion-time window 'on'
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Completion-time window 'after'
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Completion-time window 'before' to 'on'
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Completion-time window 'on' to 'after'
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Including 'completion-time window' variable in the model
Number of subjects: 3
Study: 20679548

Group type: EXPERIMENTAL
Intervention: Intra-arrest cooling with RhinoChill device
Number of subjects: 194

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 194
Study: 19378542

Group type: EXPERIMENTAL
Intervention: Droperidol (0.625 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Granisetron (1 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tropisetron (5 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Metoclopramide (20 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 150
Study: 16831962

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol, 0.014 mg/d (n = 208)
Number of subjects: 417

Group type: COMPARATOR
Intervention: Placebo (n = 209)
Number of subjects: 417
Study: 12716083

Group type: EXPERIMENTAL
Intervention: Intraperitoneal bupivacaine (0.5%); administered at different times: before dissection, after dissection, or both.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (normal saline); no bupivacaine administered.
Number of subjects: 66
Study: 11036134

Group type: EXPERIMENTAL
Intervention: Double pouch reconstruction (DP group)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Single pouch reconstruction (SP group)
Number of subjects: 41
Study: 8822339

Group type: EXPERIMENTAL
Intervention: Slow-release sodium fluoride (SR-NaF)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study: 29498176

Group type: EXPERIMENTAL
Intervention: Ergonomics training involving photography and self-assessment
Number of subjects: 135
Study: 27679946

Group type: EXPERIMENTAL
Intervention: 2-mm punch biopsy at two sites
Number of subjects: 105

Group type: COMPARATOR
Intervention: 2-mm punch biopsy at one site
Number of subjects: 105
Study: 25555673

Group type: EXPERIMENTAL
Intervention: Organ training (5 hours of cholecystectomy training on cadaver organs)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Virtual-reality training (proficiency‐based cholecystectomy training on the LapMentor)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no additional training)
Number of subjects: 30
Study: 23748514

Group type: EXPERIMENTAL
Intervention: Pramlintide
Number of subjects: 232

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Pramlintide (clinical practice trial)
Number of subjects: 232
Study: 21443793

Group type: EXPERIMENTAL
Intervention: 540,000 IU (corresponding to 13.5 mg) of cholecalciferol (VITD) dissolved in 45 ml herbal oil
Number of subjects: 25

Group type: COMPARATOR
Intervention: Matched placebo (PBO)
Number of subjects: 25
Study: 18595013

Group type: EXPERIMENTAL
Intervention: Oral pouch with preserved duodenal passage
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Aboral pouch with preserved duodenal passage
Number of subjects: 28
Study: 15777293

Group type: EXPERIMENTAL
Intervention: Lidocaine spray (40 mg)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Lidocaine (40 mg)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 122
Study: 12067171

Group type: EXPERIMENTAL
Intervention: Attenders (n=198)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Nonattenders (n=38)
Number of subjects: 236
Study: 12080833

Group type: EXPERIMENTAL
Intervention: Phenytoin and Chinese traditional drug-Jiegudan
Number of subjects: 40

Group type: COMPARATOR
Intervention: Jiegudan only (Control)
Number of subjects: 40
Study: 8533580

Group type: EXPERIMENTAL
Intervention: DTcaP
Number of subjects: 905

Group type: COMPARATOR
Intervention: DTaP
Number of subjects: 905
Study: 1911606

Group type: EXPERIMENTAL
Intervention: TRH administered by a nasal spray of 1 mg, four times daily, for 10 consecutive days starting on day 6 postpartum
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo sprays
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: TRH and Placebo
Number of subjects: 19
Study: 7013058

Group type: EXPERIMENTAL
Intervention: Physical training for 4-8 years
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no physical training)
Number of subjects: 23
Study: 31512101

Group type: EXPERIMENTAL
Intervention: Jejunostomy feeding (JF)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Nasogastric feeding (NF)
Number of subjects: 120
Study: 30934747

Group type: EXPERIMENTAL
Intervention: Senatore Cappelli wheat variety pasta
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard commercial pasta
Number of subjects: 42
Study: 27775195

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone suppositories (400 mg daily)
Number of subjects: 304

Group type: COMPARATOR
Intervention: 17-alpha-hydroxyprogesterone caproate (17OHP-C) (250 mg i.m. once a week)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Both interventions (vaginal progesterone and 17OHP-C)
Number of subjects: 304
Study: 25995057

Group type: EXPERIMENTAL
Intervention: Integrated multi-element psychosocial intervention (cognitive behavioral therapy, family intervention, and case management)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Integrated multi-element psychosocial intervention
Number of subjects: 444
Study: 23877591

Group type: EXPERIMENTAL
Intervention: Echocardiographic screening (n = 3272)
Number of subjects: 6861

Group type: COMPARATOR
Intervention: Control group (n = 3589)
Number of subjects: 6861

Group type: EXPERIMENTAL
Intervention: Echocardiographic screening
Number of subjects: 6861

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6861
Study: 21755338

Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian diathermy (LOD)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Continuation of clomiphene citrate (CC)
Number of subjects: 176
Study: 19292807

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (AIs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant tamoxifen therapy
Number of subjects: 0
Study: 17727573

Group type: EXPERIMENTAL
Intervention: Antidiuresis treatment
Number of subjects: 0
Study: 15118640

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) < 5 years
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) > or =5 years
Number of subjects: 69
Study: 11333075

Group type: EXPERIMENTAL
Intervention: Overheard speech (novel words used by others)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Directly addressed speech (novel words used directly to the child)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Overheard speech (object labels)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Overheard speech (action verbs)
Number of subjects: 88
Study: 9393428

Group type: EXPERIMENTAL
Intervention: Dental implants not coated with hydroxyapatite
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dental implants placed in the maxilla
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dental implants placed in anterior regions of the jaws
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dental implants in completely edentulous cases
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dental implants placed in bone scored as having lower quality
Number of subjects: 0
Study: 8120685

Group type: EXPERIMENTAL
Intervention: Educational module including written material and a two-hour seminar
Number of subjects: 0
Study: 3037676

Group type: EXPERIMENTAL
Intervention: Rifabutin (ansamycin LM 427)
Number of subjects: 0
Study: 29872267

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel/carboplatin
Number of subjects: 65

Group type: COMPARATOR
Intervention: paclitaxel/carboplatin
Number of subjects: 65
Study: 28572749

Group type: EXPERIMENTAL
Intervention: Pomegranate extract (POMx) 1000 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pomegranate extract (POMx)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 8
Study: 26176805

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) 25 mg/day for 12 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Anastrozole (AZ) 1 mg/day for 12 weeks
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Anastrozole (AZ)
Number of subjects: 26
Study: 23957734

Group type: COMPARATOR
Intervention: Active mesalazine 1.6 g/day plus Lactobacillus casei subsp. DG placebo (Group M)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Active Lactobacillus casei subsp. DG 24 billion/day plus mesalazine placebo (Group L)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Active Lactobacillus casei subsp. DG 24 billion/day plus active mesalazine (Group LM)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Lactobacillus casei subsp. DG placebo plus mesalazine placebo (Group P)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Group P (placebo)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Group L (placebo)
Number of subjects: 210
Study: 22012522

Group type: EXPERIMENTAL
Intervention: Risedronate 35 mg orally once weekly for six months
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 18995174

Group type: EXPERIMENTAL
Intervention: Computer-based home disease management program (Alere DayLink HF Monitoring System [HFMS])
Number of subjects: 315

Group type: COMPARATOR
Intervention: Standard heart failure care (SC: enhanced patient education, education to clinicians, and follow-up)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Both groups (HFMS and SC)
Number of subjects: 315
Study: 16311042

Group type: EXPERIMENTAL
Intervention: Full Maximum Voluntary Contraction (MVC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 20% Maximum Voluntary Contraction (MVC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Motor Unit Action Potential Trains (MUAPTs) during 20% MVC
Number of subjects: 12
Study: 12859312

Group type: EXPERIMENTAL
Intervention: ACEI treatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: NonACEI treatment (Control)
Number of subjects: 42
Study: 10479163

Group type: EXPERIMENTAL
Intervention: Self-collected vaginal swabs for HPV testing by hybrid capture assay
Number of subjects: 960
Study: 8599790

Group type: EXPERIMENTAL
Intervention: Harvesting of the IMA with opening the pleura (130 patients)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Harvesting of the IMA without opening the pleura (150 patients)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 280
Study: 1755537

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Enflurane
Number of subjects: 51
Study: 6310464

Group type: EXPERIMENTAL
Intervention: Cefotaxime sodium at a dose of 6 g/day
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Cefotaxime sodium
Number of subjects: 118

Group type: COMPARATOR
Intervention: Clindamycin and gentamicin
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Cefotaxime sodium at a dose of 3 g/day
Number of subjects: 118
Study: 30793441

Group type: EXPERIMENTAL
Intervention: Sacral nerve modulation (SNM) - subsensory setting
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sacral nerve modulation (SNM) - OFF setting
Number of subjects: 21
Study: 31280535

Group type: EXPERIMENTAL
Intervention: Sling Treatment (ST)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional Treatment (CT)
Number of subjects: 37
Study: 29390557

Group type: EXPERIMENTAL
Intervention: Leaflet group (intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonleaflet group (control)
Number of subjects: 0
Study: 26035652

Group type: EXPERIMENTAL
Intervention: DAFOs
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ADR-AFOs
Number of subjects: 10

Group type: COMPARATOR
Intervention: Barefoot
Number of subjects: 10
Study: 23871569

Group type: EXPERIMENTAL
Intervention: Dermal autograft
Number of subjects: 48

Group type: COMPARATOR
Intervention: Acellular dermal matrix (ADM)
Number of subjects: 48
Study: 21803872

Group type: EXPERIMENTAL
Intervention: American ginseng (100 mg, 200 mg, 400 mg/day)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 19538734

Group type: EXPERIMENTAL
Intervention: Medtronic CareLink monitor for remote transmission
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional method of in-person evaluations
Number of subjects: 200
Study: 16952819

Group type: EXPERIMENTAL
Intervention: 20 mL ropivacaine 0.5%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 30 mL ropivacaine 0.5%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 40 mL ropivacaine 0.5%
Number of subjects: 60
Study: 15291234

Group type: EXPERIMENTAL
Intervention: Order of report manipulation
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Event-related brain potentials analysis
Number of subjects: 14
Study: 11720748

Group type: EXPERIMENTAL
Intervention: Gemcitabine and cisplatin
Number of subjects: 0
Study: 9475308

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) levels in infected children with severe PEM
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) levels in non-infected children with severe PEM
Number of subjects: 27

Group type: COMPARATOR
Intervention: C-reactive protein (CRP) levels in healthy non-infected controls
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: C3 complement protein levels in non-infected children with severe PEM
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: C3 complement protein levels in infected children with severe PEM
Number of subjects: 27
Study: 8189743

Group type: EXPERIMENTAL
Intervention: Cue exposure treatment
Number of subjects: 31